A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease - NCT04540497
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04540497